Company Profile: Abbott Laboratories (ABT)

ABT insider trades (13 months) →

$109.40 −0.69% vs. previous close · Market cap $189.30B

Today's multi-factor rank: 444 of 461 · see the ranking

Quant500 Scores

Momentum

3.3/10

Value

4.4/10

Growth

3.9/10

Quality

4.9/10

Multifactor

4.1/10

Market and Valuation

Price & Market

Prev Close Price:$110.16

Open:$109.36

Day's Low:$108.94

Day's High:$110.60

Bid / Ask:-

Market Cap:189.30B

Enterprise Value:218.39B

52-Week Range

52-Week Low:$81.97

52-Week High:$132.03

Current position in 52-week range

52w Low-52w High

50-Day Avg:$104.21

200-Day Avg:$101.63

Volume

Volume Today:7,302,674

Avg Volume (3m):8,767,768

Avg Volume (10d):10,207,470

52-Week Change:-12.43%

vs S&P 500, 52 weeks:-

Beta:0.54

Valuation Multiples

P/E (trailing):40.67

12-month EPS and P/E from the market data provider (Yahoo Finance), not from the SEC: the latest quarter with EPS at the SEC ended Jun 30, 2026, more than 120 days ago.

P/E (forward):18.43

PEG Ratio:1.57

Price / Book:3.70

Price / Sales (TTM):3.93

EV / Revenue:4.53

EV / EBITDA:18.27

Dividends

Current yield:2.29%

Annual Dividend Rate:$2.52

Dividend Trailing:$2.52

Yield Trailing:2.29%

5-Year Avg Yield:1.86%

Payout Ratio:78.71%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):48.23B

Gross Profit:27.53B

EBITDA:11.95B

Net Income (TTM):4.68B

Rev Growth (YoY):+14.50%

Earnings Growth (YoY):-43.70%

Quarterly earnings growth (YoY):-44.00%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):$2.69

12-month EPS and P/E from the market data provider (Yahoo Finance), not from the SEC: the latest quarter with EPS at the SEC ended Jun 30, 2026, more than 120 days ago.

EPS Forward (Est.):$5.94

Revenue Per Share:$27.77

Cash Per Share:-

Book Value:$29.54

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:5.60B

Total Debt:32.72B

Net Debt (Debt - Cash):27.12B

Debt / Equity:63.21%

Current Ratio:-

Quick Ratio:-

Cash Flows

Operating Cash Flow:-

Free Cash Flow (FCF):-

FCF Yield (FCF / Market Cap):-

Enterprise Value:218.39B

EV / Revenue:4.53

EV / EBITDA:18.27

Profitability

ROE (Return on Equity):-

ROA (Return on Assets):-

P/E (trailing):40.67

P/E (forward):18.43

Price / Book:3.70

PEG Ratio:1.57

52-Week Change:-12.43%

S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$2.69

12-month EPS and P/E from the market data provider (Yahoo Finance), not from the SEC: the latest quarter with EPS at the SEC ended Jun 30, 2026, more than 120 days ago.

EPS Forward (Est.):$5.94

P/E (forward):18.43

PEG Ratio:1.57

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$27.77

Cash Per Share:-

Book Value:$29.54

Cash Flows (TTM)

Free Cash Flow:-

Operating Cash Flow:-

EBITDA:11.95B

Total Revenue (TTM):48.23B

Net Income (TTM):4.68B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:1,730,383,296

Float (free shares):1,720,122,123

Short interest (shares):17,386,736

Short % of float:-

Short Ratio (days to cover):1.84

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Abbott Laboratories (ABT) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
8-K	2026-10-21	View filing ↗
8-K	2026-08-20	View filing ↗
10-Q	2026-07-28	View filing ↗
8-K	2026-07-16	View filing ↗
11-K	2026-06-18	View filing ↗
SD	2026-05-27	View filing ↗
10-Q	2026-04-29	View filing ↗
8-K	2026-04-27	View filing ↗
S-8	2026-04-24	View filing ↗
8-K	2026-04-17	View filing ↗

Company and Executive Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

General Information

Headquarters:United States

City:Abbott Park

Employees:122,000

Sector:Healthcare

Industry:Medical Devices

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Robert B. Ford	Executive Chairman & CEO	51	4.43M
Mr. Philip P. Boudreau	CFO & Executive VP of Finance	52	2.10M
Mr. Daniel Gesua Sive Salvadori	Executive VP and Group President of Established Pharmaceuticals & Nutritional Products	46	1.52M
Mr. Christopher J. Scoggins	Executive Vice President of Diabetes Care	55	2.06M
Ms. Lisa D. Earnhardt	Executive VP & Group President of Medical Devices	55	2.39M
Ms. Sabina Ewing	Senior VP of Business & Technology Services and Chief Information Officer	51	-
Mr. Michael Comilla	Vice President of Investor Relations.	-	-
Erica L. Battaglia	VP and Chief Ethics & Compliance Officer	-	-

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Abbott Laboratories (ABT): Quantitative Analysis

Name: Factor scores for Abbott Laboratories (ABT)
Creator: Quant500
License: https://quant500.com/legal

Abbott Laboratories (ABT) — Healthcare — Medical Devices. ABT is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, ABT has returned −10.7% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

ABT ranks 444 of 461 on today's multifactor score, and 54 of the 55 Healthcare companies that score. Its strongest factor is quality (Z -0.08, ranked 237 of 468); its weakest is momentum (Z -1.04, ranked 437 of 494). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.535	444 of 461 ↑1
Momentum	-1.036	437 of 494 ↑14
Value	-0.361	315 of 489
Quality	-0.075	237 of 468
Growth	-0.669	455 of 489

Market data

Metric	Value
Price	$109.40
Market Cap	189.30B
P/E	40.67
Revenue (last 12 months)	48.23B
Price / book	3.70
Book value per share	$29.54
52-week range	$81.97 – $132.03
Dividend yield	2.29%
Beta	0.54
Average volume	8,767,768
Shares outstanding	1.73B
Short interest (% of float)	1.12% (as of Oct 15, 2026)

When does ABT report earnings? 12 of its last 12, before the open →

What are ABT insiders doing? 60 transactions filed with the SEC, of them 5 buys and 10 sells, the last one on Sep 23, 2026 →

ABT latest SEC filings

Annual report (10-K): filed Feb 20, 2026, fiscal year ended Dec 31, 2025 · view the filing on sec.gov
Quarterly report (10-Q): filed Jul 28, 2026 · view the filing on sec.gov
Earnings release (8-K): Oct 21, 2026, before the open · view the 8-K on sec.gov

Filing dates on EDGAR, the SEC's public registry. All ABT filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Abbott Laboratories (ABT)

When does Abbott Laboratories report earnings?

Abbott Laboratories has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 before the open (SEC filings through Oct 21, 2026). ABT earnings dates and times, quarter by quarter →

What is Abbott Laboratories's P/E ratio?

Abbott Laboratories's P/E (price over earnings per share for the last twelve months) is 40.7 at the Nov 3, 2026 close. That EPS is the 12-month figure from the market data provider (Yahoo Finance), not the SEC one. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Abbott Laboratories is above its sector median. Healthcare stocks, company by company →

Where does Abbott Laboratories rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Abbott Laboratories ranks 444 of 461, and 54 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Abbott Laboratories insiders bought or sold shares?

The latest open-market purchase of Abbott Laboratories shares filed with the SEC (Form 4) was on May 7, 2026, by a director, for $174k. The latest sale was on Sep 2, 2026, by an officer, for $3k. In total, from August 2025 through Nov 3, 2026: 5 purchases and 10 sales by directors, officers and large shareholders. All ABT insider trades →

Does Abbott Laboratories pay a dividend?

Yes. Its dividend yield is 2.29% at the Nov 3, 2026 close (annual dividend of $2.52 per share). The latest recorded ex-dividend date is Oct 15, 2026.

What sector is Abbott Laboratories in, and which index?

Abbott Laboratories is classified in the Healthcare sector (industry: Medical Devices), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

Valuation multiples: P/E, P/B, EV/EBITDA and their trapsWhy the P/E and the price-to-book in the table above cannot be compared across sectors, and what a low P/E can hide.
Value and momentum: the two that have survived bestWhat the value and momentum scores on this page actually measure, and why they are the two factors that have best survived scrutiny.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
Sales growth: the driver that gets overestimated mostWhat sits behind the growth score and the twelve-month revenue, and why it is the number people extrapolate too far most often.
Dividends and payout: high is not always goodThis company pays a dividend and its yield is in the table above: when a high figure is good news and when it is a warning.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile: Abbott Laboratories (ABT)

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Abbott Laboratories (ABT) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Abbott Laboratories (ABT): Quantitative Analysis

Factor scores

Market data

ABT latest SEC filings

Frequently asked questions about Abbott Laboratories (ABT)

When does Abbott Laboratories report earnings?

What is Abbott Laboratories's P/E ratio?

Where does Abbott Laboratories rank on Quant500?

Have Abbott Laboratories insiders bought or sold shares?

Does Abbott Laboratories pay a dividend?

What sector is Abbott Laboratories in, and which index?

What is behind these numbers